FLOOR PLAN: MAIN MEZZANINE and CONVENTION FLOOR Main Mezzanine diagnosis between Irritable Bowel Syndrome (IBS) and Inflammatory Bowel areas, procedure documentation, image management, infection daily and almost all hospitals, with a National Network U1043, INSERM, Toulouse, France; 2
Previous PDF | Next PDF |
[PDF] CD033418 cddw2018_exhibitabstractguideindd - Canadian
FLOOR PLAN: MAIN MEZZANINE and CONVENTION FLOOR Main Mezzanine diagnosis between Irritable Bowel Syndrome (IBS) and Inflammatory Bowel areas, procedure documentation, image management, infection daily and almost all hospitals, with a National Network U1043, INSERM, Toulouse, France; 2
[PDF] Complete thesis - Rijksuniversiteit Groningen
Both national and international treatment guidelines advise to use a step?up protocol of irritable bowel syndrome-type symptoms in paediatric inflammatory bowel daily functioning of the child may additionally guide management Participants defecated onto a stool collection sheet (Alere Health BV, The Netherlands)
[PDF] fusion indd - www6inrafr
Daily growth, from clock gene expression to the phospho-proteome and biomass 12:05-12:20 Seed Longevity of Arabidopsis Natural Variations after Priming Treatments Masanori Kaji Light sheet microscopy: a versatile tool for single cell calcium analysis specific mutants, markers and protocols that now provide an
[PDF] APRES 29-3 for pdfindd
issue a limited supply (3–5 days) of medication, so the patient may need another Paris, France 1 - manufacturer guidelines define patients with mild asthma as those who experience contact with the study nurse, a detailed written action plan, and were sympathetic dystrophy), fibromyalgia, irritable bowel syndrome
[PDF] 30 décembre 2015 - Gestion De Projet
[PDF] 30 découverte des honneurs cachés - Anciens Et Réunions
[PDF] 30 dessins humoristiques sur la dette le chômage et la précarité 08 - Anciens Et Réunions
[PDF] 30 ème RALLYE NATIONAL TOUT TERRAIN DUNES ET MARAIS - Anciens Et Réunions
[PDF] 30 euros pour une aprem au TOP!!!
[PDF] 30 F 1 - Archives départementales de la Nièvre
[PDF] 30 Gratinierte King Prawns in Kurkuma
[PDF] 30 H Sœurs de la Croix de Magnac-Laval (1664) - France
[PDF] 30 INSTITUTIONS FAISANT APPEL A LA GÉNÉROSITÉ PUBLIQUE - France
[PDF] 30 Jahre - Friedrichstrasse.de
[PDF] 30 Jahre Casino Tanzclub "Rot
[PDF] 30 Jahre Erfolgsstory
[PDF] 30 Jahre ERP: Rück- und Ausblick
[PDF] 30 Jahre Hausnotruf-Dienst
EXHIBIT & ABSTRACTGUIDE
RENFLEXIS is a trademark of Merck Sharp & Dohme Corp. Used under license.© 2017 Merck Canada Inc. All rights reserved
VISIT US AT BOOTH 105Merck Biosimilars
BIOSIMILARS
4Table of Contents
Sponsors & Exhibitors 5
Corporate Sponsors
6Gastro Expo Schedule
8Floor Plans
9-10Exhibitor Bios
11-172017 CAG Resear
ch Program 18Oral Presentations
21-33Poster Session I
35-128
Poster Session II
129-221
Author Index
222-229
5Affinity Diagnostics Corp.
Allergan Canada
ALPCO Diagnostics
AMT Surgical
Apollo Endosurgery, Inc.
ATGen Canada Inc.
BioScript Solutions
Boston Scientific Ltd.
Buhlmann Diagnostic Corp.
Canadian Digestive Health Foundation
Celgene Inc.
Cook Medical
Crohn's and Colitis Canada
EndoSoft LLC.
Gastrointestinal Society Innomar StrategiesLaborieLupin Pharma Canada Ltd.McKesson CanadaMedReleafMedtronicMylan EPDNKS HealthOxford University Press, Inc.Pendopharm, a division of PharmascienceProcter & GambleQualisys Diagnostics Inc.Stanton Territorial Health AuthorityVantage Endoscopy
CDDW™ 2018 Sponsors
CDDW™ 2018 Exhibitors
6 fl fl fl flReceive regular email alerts as soon as new
content is published online. fl fl fl flReceive regular email alerts as soon as new
content is published online. fl fl fl flReceive regular email alerts as soon as new
content is published online.Conference Information
GASTRO EXPO A
FRIDAY, FEBRUARY 9, 2018
11h45-12h15
Intercept Pharma Canada Inc.
Long-term data for obeticholic acid in PBC
Vlad Popovic, MD
14h30-15h00
Janssen Inc.
EXITING HELL BAR: A Real Life Patient Story
Dr. Remo
Panaccione
SATURDAY, FEBRUARY 10, 2018
10h30-11h00
Janssen Inc.
LOST AND FOUND: A Real Life Crohn"s Story
Dr. Gabor Kandel & Crohn's and Colitis Canada
12h45-13h15
AbbVie
IBD Research in Canada: Past, Present and Future,
AbbVie Medical Affairs
15h00-15h30
Allergan (visit booth #108 for more details)
SUNDAY, FEBRUARY 11, 2018
12h45-13h15
AbbVie
IBD Research in Canada: Past, Present and Future,
AbbVie Medical Affairs
GASTRO EXPO B
11h45-12h15
Allergan (visit booth #108 for more details)
14h30-15h00
Olympus Canada Inc.
Advanced Polyp Detection
Dr. Seth A. Gross, NYU Langone Medical Centre
10h30-11h00
PENTAX Medical (visit booth #116 for more details)12h45-13h15
Gilead Sciences Canada, Inc. (visit booth #131 for more details)15h00-15h30
Takeda Canada, Inc.
Case Based Discussions
10h30-11h00
Shire Pharma Canada ULC
Tips for Managing Patients Requiring IV Hydration
Dr. Don Duerksen
12h45-13h15
Ferring Pharmaceuticals (visit booth #130 for more details) 9FLOOR PLAN: MAIN MEZZANINE and CONVENTION FLOOR
Main Mezzanine
CONFEDERATION
3CONFEDERATION
5CAG STAFF
ONLYTERRITORIESALBERTA
QUEBEC
BRITISH
COLUMBIAMANITOBA
ALGONQUIN
LIBRARY YORK
YORKSTATION
BARCONFEDERATION
6TUDOR
7TUDOR
8SASKATCHEWANNOVA
SCOTIANEW
BRUNSWICK
PRINCE
EDWARD
ISLAND
NFLDConvention Floor
CONCERT
HALLCONCERT
HALL FOYERCDDW™ REGISTRATION
CAG GALASPEAKER
READYROOMNETWORK
HALLSALON B
SALON AONTARIO
CANADIAN
TORONTO
BALLROOM
12 10FLOOR PLAN: NETWORK HALL
NETWORK HALL
6F&BF&B
54105104
102
101
103106
107108109110111124
125126
127
128
129
130
131
132
133
134
123122121120119118
117116115114113112
135136
CDDW™
LOUNGE
CDDW™
LOUNGEGASTRO EXPO B
GASTRO EXPO A
AbbVie 102
11EXHIBITORS
Company:
AbbVie
Address:
8401 Trans-Canada
St-Laurent, QC H4S 1Z1
Contact:
Chantal Néron
T elephone:888-703-3006
Email:
chantal.ner on@abbvie.comBooth #:
102AbbVie is a global, resear
ch-based biopharmaceutical company that combines the focus and passion of a leading-edge biotech with the expertise and structure of a long-established pharmaceutical leader. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. The company has several core areas of focus, including gastroenterology and hepatitis C. AbbVie aims to help patients live healthier lives and collaborate on sus- tainable healthcare solutions. For further information, please visit www.abbvie.caCompany:
AFFINIT
Y Diagnostics Corp.
Address:
194 Wildcat Road
Tor onto, ON M3J 2N5Contact:
Daniel Libertucci
T elephone:416-650-6300
Booth #:
128AFFINIT
Y Diagnostics Corp. is a provider of high quality
in-vitro diagnostic assays for clinical and research laboratory use. Our Featured Products for CDDW2018 are the IDK® CALPROTECTIN ELISA, and the
PREVENTIS QUANTONCAL point-of-care smartphone
device. Fecal Calprotectin is a marker for inflammatory and neoplastic gastrointestinal diseases, and is also an ideal marker for therapy monitoring in IBD patients. The IDK® Calprotectin ELISA enables the differential diagnosis between Irritable Bowel Syndrome (IBS) andInflammatory Bowel Disease (IBD). The PREVENTIS
QUANTONCAL device provides the same perfor-
mance as the IDK® Calprotectin ELISA, but with theEHQHdWVRIDWKRPHWHVWLQJDQGVPDU
WSKRQH
integration. At AFFINITY, our commitment to providing
quality in our products and excellence in our service is the backbone of our business, and the strength of our organization. For more information please e-mail us at:Company:
Allergan Canada
Addr ess:85 Enterprise Blvd., Suite 500
Markham, ON L6G 0B5
Contact:
Sara Colman
Telephone:
800-668-6427
Email:
MR-General_Inquir
y@Allergan.comBooth #:
108Allergan is a global specialty pharmaceutical com- pany with a full GI por tfolio which includes products like VIBERZI®, CONSTELLA®, ASACOL® 800 and SALOFALK®. Additionally, Allergan has an exciting GI pipeline in clinical development, with products for gastroparesis, NASH and IBD.